pre-market authorization of its CARA SYSTEM, a machine-learning-enabled medical device (MLMD). To ensure a smooth regulatory process, DIAGNOS has engaged ORA, a leading clinical research organization ...
The Board approved a new share repurchase authorization enabling Applied to buy back an additional $10 billion of its shares over time. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback